开源证券给予皓元医药买入评级，公司信息更新报告：前端业务高速增长驱动利润率提升，业绩超预期

七印授权

30BAVHUOLY0OY9IRKPMSCVATOSRJ196JE0SYRH3W90S6IH3HWP

2024-08-29 15:09:18

article

3BFA80F750993E4B0C8AF039D2ED3A55E3A971869FE0B36835389C33F8C0C5B2

zh-CN

F1722BF5545DAA771A01AACBAB2DE8BF946DC900

17032654

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

6516d7785a2370b7fede155b6768b8b012e50d95cd86e6d6c0429c8424dfce2e7100fbec44bf7e35bdaf11b37124857140ff15ea221f6484e96b0154609d58111c

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"100000"},"type":"cm"}

yuanben_66d08f1e0219b2.72547719

原本认证

32OLRS3ZU5F5QT8B8IJWRVN95PL1S0B5CJBTI9M3WZLYKCN071

https://www.yuanben.io/article/187afee6-8d23-44f3-bce3-6718f0ebeab6

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}